Charles River Laboratories International, Inc. (NYSE:CRL) is looking for acquisitions. In an earnings call, Chairman, President, and Chief Executive Officer, James C. Foster said, “I think our greatest strength is the uniqueness and diversity of our portfolio. It's clearly our greatest competitive advantage. We continue to strengthen and add to this portfolio, both by licensing technologies and through M&A. We will continue to be acquisitive and continue to build out this portfolio so that there really is no competitive response. And so the clients who want to buy across the whole drug development pipeline can continue to do so.”